Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
This randomized, double-blind, placebo-controlled, multi-center study investigated the clinical efficacy of two probiotic strains on abdominal pain severity and symptomology in irritable bowel syndrome (IBS). Three hundred and thirty adults, aged 18 to 70 years, with IBS according to Rome IV criteria were allocated (1:1:1) to receive placebo, Lactobacillus acidophilus DDS-1 (1 × 1010 CFU/day) or Bifidobacterium animalis subsp. lactis UABla-12 (1 × 1010 CFU/day) over six weeks. The primary outcome was the change in Abdominal Pain Severity - Numeric Rating Scale (APS-NRS). Over the intervention period, APS-NRS was significantly improved in both probiotic groups vs. placebo in absolute terms (DDS-1: −2.59 ± 2.07, p = 0.001; UABla-12: −1.56 ± 1.83, p = 0.001) and in percentage of significant responders (DDS-1: 52.3%, p < 0.001); UABla-12 (28.2%, p = 0.031). Significant amelioration vs. placebo was observed in IBS Symptom Severity Scale (IBS-SSS) scores for L. acidophilus DDS-1 (−133.4 ± 95.19, p < 0.001) and B. lactis UABla-12 (−104.5 ± 96.08, p < 0.001) groups, including sub-scores related to abdominal pain, abdominal distension, bowel habits and quality of life. Additionally, a significant normalization was observed in stool consistency in both probiotic groups over time and as compared to placebo. In conclusion, L. acidophilus DDS-1 and B. lactis UABla-12 improved abdominal pain and symptom severity scores with a corresponding normalization of bowel habits in adults with IBS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
(1988) · Cited by 4,111
FRANCIS, C. Y., MORRIS, J., & WHORWELL, P. J. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.142318000.x · Cited by 1,708 · cited 8×
“IBS symptom severity was assessed via the IBS Symptom Severity Scale (IBS-SSS) [23].”
MethodInfluentialActivation of the mucosal immune system in irritable bowel syndrome
Chadwick, V. S., Chen, W., Shu, D., Paulus, B., Bethwaite, P., Tie, A., & Wilson, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.33579 · Cited by 833 · cited 1×
“There is evidence of an activation of the intestinal immune system in IBS resulting in inflammation, including augmented mucosal intraepithelial lymphocytes and mast cells [42,43].”
BackgroundLactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1521 · Cited by 793 · cited 1×
“acidophilus has been shown to normalize visceral pain responses via induced expression of opioid and cannabinoid receptors in the gut [45].”
BackgroundSelf-citationPatrick, D. L., Drossman, D. A., Frederick, I. O., Dicesare, J., & Puder, K. L. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018831127942 · Cited by 761 · cited 1×
“IBS-related quality of life (QoL) was assessed via the IBS-QoL, a 34-item questionnaire with each item rated on a 5-point scale (range: 34–170), with increasing scores indicating deteriorating quality of life [25].”
MethodLiang, P., Liu, S., Xu, F., Jiang, S., Yan, J., He, Q., Liu, W., Lin, C., Zheng, F., Wang, X., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00001 · Cited by 669
Ford, A. C., Moayyedi, P., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Quigley, E. M. M. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.187 · Cited by 645 · cited 2×
“controlled trials with a dichotomous outcome enrolling a total of 4403 participants [7,11].”
BackgroundFord, A. C., Harris, L. A., Lacy, B. E., Quigley, E. M. M., & Moayyedi, P. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15001 · Cited by 619 · cited 1×
“controlled trials with a dichotomous outcome enrolling a total of 4403 participants [7,11].”
BackgroundPathophysiology of irritable bowel syndrome
Holtmann, G. J., Ford, A. C., & Talley, N. J. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30023-1 · Cited by 590 · cited 1×
“Irritable bowel syndrome (IBS), a functional disorder of the gastrointestinal tract, is characterized by chronic or recurrent abdominal pain and altered bowel habits [1].”
Background
Research works printed but not linked: 1
- Nagala R. Routray C. Clinical Case Study—Multispecies probiotic supplement minimizes symptoms of irritable bowel syndrome US Gastroenterol. Hepatol. Rev. 2011 7 1 2
Cited by
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Vasant, D. H., Paine, P. A., Black, C. J., Houghton, L. A., Everitt, H. A., Corsetti, M., Agrawal, A., Aziz, I., Farmer, A. D., Eugenicos, M. P., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324598 · Cited by 592
Rastogi, S., & Singh, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1042189 · Cited by 326
Lactobacillus and intestinal diseases: Mechanisms of action and clinical applications
Huang, R., Wu, F., Zhou, Q., Wei, W., Yue, J., Xiao, B., & Luo, Z. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127019 · Cited by 250
Abouelela, M. E., & Helmy, Y. A. (2024) · Microorganisms · doi:10.3390/microorganisms12030430 · Cited by 238
“Those who supplemented with L. acidophilus DDS-1 and B. lactis UABla-12 also witnessed a normalization of stool patterns and experienced enhanced relief from abdominal pain throughout the intervention period [94].”
BackgroundWorld Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics
Guarner, F., Sanders, M. E., Szajewska, H., Cohen, H., Eliakim, R., Herrera-deGuise, C., Karakan, T., Merenstein, D., Piscoya, A., Ramakrishna, B., et al. (2024) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002002 · Cited by 209
Savarino, E., Zingone, F., Barberio, B., Marasco, G., Akyuz, F., Akpinar, H., Barboi, O., Bodini, G., Bor, S., Chiarioni, G., et al. (2022) · United European Gastroenterology Journal · doi:10.1002/ueg2.12259 · Cited by 146
“Of these, four studies were performed in more than 100 patients.(151,152) In particular: (1) a study performed in 313 Rome IV IBS patients showed that specific probiotics improved”
BackgroundEfficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis
Zhang, T., Zhang, C., Zhang, J., Sun, F., & Duan, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.859967 · Cited by 125
“Among the included studies, 29 RCTs (Niedzielin et al., 2001; Bauserman and Michail, 2005; Niv et al., 2005; O’Mahony et al., 2005; Whorwell et al., 2006; Sinn et al., 2008; Enck et al., 2009; Ligaarden et al., 2010; Choi et al., 2011; Guglielmetti et al., 2011; Kabir et al., 2011; Dapoigny et al., 2012; Ducrotté et a…”
BackgroundYang, B. K., Yue, Y., Chen, Y., Ding, M., Li, B., Wang, L., Wang, Q., Stanton, C., Ross, R. P., Zhao, J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.746585 · Cited by 90
Srivastava, S., Basak, U. O., Naghibi, M., Vijayakumar, V., Parihar, R., Patel, J. A., Jadon, P., Pandit, A., Dargad, R., Khanna, S., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2338322 · Cited by 80
Self-citationXu, H., Ma, C., Zhao, F., Chen, P., Liu, Y., Sun, Z., Cui, L., Kwok, L. Y., & Zhang, H. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02437-4 · Cited by 64
Wu, Y., Li, Y., Zheng, Q., & Li, L. (2024) · Nutrients · doi:10.3390/nu16132114 · Cited by 81
Liu, Y., Yu, X., Yu, L., Tian, F., Zhao, J., Zhang, H., Qian, L., Wang, Q., Xue, Z., Zhai, Q., et al. (2020) · Engineering · doi:10.1016/j.eng.2020.06.026 · Cited by 65
Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review
Chlebicz-Wójcik, A., & Śliżewska, K. (2021) · Biomolecules · doi:10.3390/biom11081154 · Cited by 60
“Paper Research Type ParticipantsSelection Criteria Participants 1 IBS Subtype Preparation (Dosage) Placebo/Control (Dosage) Duration Outcomes Martoni et al. (2020) [92] The randomized, double-blind, placebocontrolled, multicenter study Rome IV 336 males/females18–70 y wd Microcrystalline cellulose,…”
BackgroundMethodInfluentialGuo, S., Ma, T., Kwok, L. Y., Quan, K., Li, B., Wang, H., Zhang, H., Menghe, B., & Chen, Y. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2395092 · Cited by 59
de Sequeira, C. L. M., Kaeber, M., Cekin, S., Enck, P., & Mack, I. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163497 · Cited by 51
“…et al. (2007) Ki Cha et al. (2012) Kruis et al. (2011) Lorenz - Zuniga et al. (2014) Lyra et al. (2016) Majeed et al. (2016) Majeed et al. (2018) Martoni et al. (2020) Niv et al. (2005) O'Mahony et al. (2005) Pinto-Sanchez et al. (2017) Preston et al. (2018) Simren et al. (2010) Sisson et al.…”
Xie, P., Luo, M., Deng, X., Fan, J., & Xiong, L. (2023) · Nutrients · doi:10.3390/nu15173856 · Cited by 50
Xia, B., Lin, T., Li, Z., Wang, J., Sun, Y., Wang, D., Ye, J., Zhang, Y., Kou, R.-W., Zhao, B., et al. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c03087 · Cited by 49
Salinas, E., Reyes-Pavón, D., Cortes‐Perez, N. G., Torres-Maravilla, E., Bitzer-Quintero, O. K., Langella, P., & Bermúdez‐Humarán, L. G. (2021) · Microorganisms · doi:10.3390/microorganisms9081634 · Cited by 49
“These results were attributed to the previously demonstrated immune-regulatory and anti-inflammatory roles of the two probiotic strains [88].”
ResultGalli, V., Venturi, M., Mari, E., Guerrini, S., & Granchi, L. (2022) · Fermentation · doi:10.3390/fermentation8080407 · Cited by 42
Liu, Y., Xiao, W., Yu, L., Tian, F., Wang, G., Lu, W., Narbad, A., Chen, W., & Zhai, Q. (2020) · Food & Function · doi:10.1039/d0fo02616f · Cited by 36
Min, U.-G., Jin, Y.-J., Jang, Y. J., Lim, J.-H., & Kim, B. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1302093 · Cited by 37
An Overview of Gut Microbiota and Colon Diseases with a Focus on Adenomatous Colon Polyps
Pop, O. L., Vodnar, D. C., Diaconeasa, Z. M., Istrati, M., Bințințan, A., Bintintan, V. V., Suharoschi, R., & Gabbianelli, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197359 · Cited by 37
“lactis UABla-12 Capsule; 1/d for >6 wk Abdominal pain significantly improved [103]”
BackgroundLópez-Santamarina, A., Mondragón, A. D. C., Cardelle‐Cobas, A., Santos, E. M., Porto-Arias, J. J., Cepeda, A., & Miranda, J. M. (2023) · Nutrients · doi:10.3390/nu15133070 · Cited by 37
“These strains, alone or in combination, have previously been shown to reduce the severity of abdominal pain and irritable bowel syndrome symptoms [88,90,93], improve functional constipation [94], provide symptomatic relief in cases of lactose intolerance [94], and show protective effects against atopic dermatitis [95]…”
BackgroundProbiotics, Anticipation Stress, and the Acute Immune Response to Night Shift
West, N. P., Hughes, L., Ramsey, R., Zhang, P., Martoni, C., Leyer, G. J., Cripps, A. W., & Cox, A. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.599547 · Cited by 40
Self-citationSabaté, J., & Iglicki, F. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i7.732 · Cited by 36
How to Improve Health with Biological Agents—Narrative Review
Zawistowska-Rojek, A., & Tyski, S. S. (2022) · Nutrients · doi:10.3390/nu14091700 · Cited by 34
Stress triggers gut dysbiosis via CRH-CRHR1-mitochondria pathway
Zhang, Y., Li, X., Lu, S., Guo, H., Zhang, Z., Zheng, H., Zhang, C., Zhang, J., Wang, K., Pei, F., et al. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00571-z · Cited by 43
Konstantis, G., Efstathiou, S., Pourzitaki, C., Kitsikidou, E., Germanidis, G. S., & Chourdakis, M. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.03.019 · Cited by 38
Efficacy of probiotics in pediatric atopic dermatitis: A systematic review and meta‐analysis
Xue, X., Yang, X., Shi, X., & Deng, Z. (2023) · Clinical and Translational Allergy · doi:10.1002/clt2.12283 · Cited by 35
Chen, M., Lu, Y., Xie, C.-R., Wang, X., Feng, S., Xiao, X.-Y., & Zheng, H. (2023) · International Journal of Surgery · doi:10.1097/js9.0000000000000658 · Cited by 40
Xie, C.-R., Tang, B., Shi, Y., Peng, W.-Y., Ye, K., Tao, Q., Yu, S., Zheng, H., & Chen, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.853011 · Cited by 35
“, 2021), eight trials assessed Bifidobacterium (Whorwell et al., 2006; Agrawal et al., 2009; Guglielmetti et al., 2011; Charbonneau et al., 2013; Pinto–Sanchez et al., 2017; Andresen et al., 2020; Lewis et al., 2020; Martoni et al., 2020), and five trials assessed Saccharomyces (Choi et al.”
BackgroundNoguera‐Fernández, N., Candela‐González, J., & Orenes‐Piñero, E. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400429 · Cited by 25
Effects of probiotics and its fermented milk on constipation: a systematic review
Yan, J., Wu, M., Zhao, W. K., Kwok, L. Y., & Zhang, W. (2023) · Food Science and Human Wellness · doi:10.1016/j.fshw.2023.03.024 · Cited by 24
van der Geest, A. M., Schukking, I., Brummer, R. J., van de Burgwal, L., & Larsen, O. F. A. (2022) · Beneficial Microbes · doi:10.3920/bm2021.0123 · Cited by 23
Zhang, W. X., Shi, L., Zhou, M. S., Wu, J., & Shi, H. Y. (2023) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001758 · Cited by 29
Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis
Yang, R., Jiang, J., Ouyang, J., Zhao, Y., & Xi, B. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.02.025 · Cited by 27
Papale, A. J., Flattau, R., Vithlani, N., Mahajan, D., & Nadella, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13226948 · Cited by 28
Chen, Y., Li, Y., Wang, X., Wang, Z., Hou, J., Su, S., Zhong, W., Xu, X. J., Zhang, J., Wang, B., et al. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i5.532 · Cited by 21
Lin, J., Zhang, Y., Wang, K., Wang, J., Kou, S., Chen, K., Zheng, W., & Chen, R. (2023) · European Journal of Nutrition · doi:10.1007/s00394-023-03184-y · Cited by 21
Probiotics in Gastrointestinal Diseases: All that Glitters Is Not Gold
Compare, D., Sgamato, C., Nardone, O. M., Rocco, A., Coccoli, P., Laurenza, C., & Nardone, G. (2021) · Digestive Diseases · doi:10.1159/000516023 · Cited by 25
Martoni, C., Srivastava, S., Damholt, A. B., & Leyer, G. J. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i28.4451 · Cited by 31
Self-citationAbdellah, S. A., Gal, C., Laterza, L., Velenza, V., Settanni, C. R., Napoli, M., Schiavoni, E., Mora, V., Petito, V., & Gasbarrini, A. (2022) · Digestive Diseases · doi:10.1159/000526712 · Cited by 17
Shastri, M. D., Chong, W. C., Vemuri, R., Martoni, C., Adhikari, S., Bhullar, H., Kunde, D., Tristram, S. G., & Eri, R. D. (2020) · Microorganisms · doi:10.3390/microorganisms8111758 · Cited by 17
Self-citationMartoni, C. J., Frederiksen, A. K. S., Damholt, A., & Leyer, G. (2022) · International Journal of Women's Health · doi:10.2147/ijwh.s341046 · Cited by 12
Self-citationEvaluation of the efficacy of probiotics as treatment in irritable bowel syndrome
Ruiz-Sánchez, C., Escudero‐López, B., & Fernández‐Pachón, M. (2024) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2024.01.003 · Cited by 18
Gut bacteria: an etiological agent in human pathological conditions
Islam, M. M., Mahbub, N. U., Hong, S., & Chung, H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1291148 · Cited by 18
Skrzydło-Radomańska, B., Prozorow-Król, B., Kurzeja-Mirosław, A., Cichoż‐Lach, H., Laskowska, K., Majsiak, E., Bierła, J. B., Agnieszka, S., & Cukrowská, B. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144838 · Cited by 18
“showed that Bifidobacterium lactis UABla-12 significantly reduced abdominal pain severity in IBS patients comparing with the placebo [24].”
BackgroundGan, D., Chen, J., Tang, X., Xiao, L., Martoni, C., Leyer, G. J., Huang, G., & Li, W. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.985308 · Cited by 18
“Previously, the two strains, alone or in combination, were shown to improve abdominal pain severity and symptomology in irritable bowel syndrome, support abdominal symptom relief for lactose intolerance, reduce the severity of atopic dermatitis and reduce the severity and duration of acute viral respiratory tract infe…”
BackgroundSelf-citationLactobacillus acidophilus DDS-1 Modulates the Gut Microbial Co-Occurrence Networks in Aging Mice
Vemuri, R., Martoni, C., Kavanagh, K., & Eri, R. D. (2022) · Nutrients · doi:10.3390/nu14050977 · Cited by 17
“Conversely, less dominant genera such as Bacteroides, Lachnospira, and Oscillospira, as well as Verrucomicrobia, had higher associations across the groups, suggesting the importance of the absence or presence of particular genera in modulating microbial community, but not based on the taxonomic structure [15,16,19,27,…”
BackgroundSelf-citationUmeano, L., Iftikhar, S., Alhaddad, S. F., Paulsingh, C. N., Riaz, M. F., Garg, G., & Mohammed, L. (2024) · Cureus · doi:10.7759/cureus.58306 · Cited by 18
“Two studies compared two different strains of bacteria with a placebo, administering the supplements in a ratio of 1:1:1 [25,27].”
BackgroundInfluentialLei, Y., Sun, X., Ruan, T., Lu, W., Deng, B., Zhou, R., & Mu, D. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuae217 · Cited by 14
Lu, H., Nguyen, N. T. K., Panwar, R., Lin, C., Cross, T.-W., & Lin, S. (2025) · Autism Research · doi:10.1002/aur.70091 · Cited by 14
“Furthermore, a probiotic intervention lasting several weeks has been found to alleviate abdominal pain and bloating, improve stool consistency, and enhance quality of life in patients with irritable bowel syndrome (Martoni et al. 2020).”
Taha, H. A., Issa, A., Muhanna, Z., Al-Shehab, M., Wadi, T., Awamleh, S., Ateiwi, Y. A., Abusido, M., & Berggren, V. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1648118 · Cited by 16
Oh, C. K., Chung, H. H., Kim, Y. J., & Kim, J. B. (2025) · Nutrients · doi:10.3390/nu17050763 · Cited by 11
Ginsenoside Reshapes Intestinal Microecology to Alleviate Microgravity Stress
Wang, Y., Chen, T., Shi, Z., Dong, L., Li, M.-T., Peng, B., Li, Q., Pan, R., Xiao, S., Yang, Q., et al. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s486371 · Cited by 11
“40 43 Recent studies have shown that changes in the abundance of lactobacilli, ruminococcus , and Oscillospira directly affect intestinal permeability, systemic inflammation, and macrophage dysfunction.”
Marchix, J., Quénéhervé, L., Bordron, P., Aubert, P., Durand, T., Oullier, T., Blondeau, C., Abdellah, S. A., Varannes, S. B. D., Chaffron, S., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11020277 · Cited by 9
Dietary interventions and irritable bowel syndrome – what really works?
Blaga, T. S., Cozma-Petruț, A. P., & Dumitrascu, D. L. (2020) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000706 · Cited by 11
“Martoni CJ, Srivastava S, Leyer GJ. Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 improve abdominal pain severity and symptomology in irritable bowel syndrome: randomized controlled trial.”
BackgroundJang, Y. J., Min, B., Lim, J. H., & Kim, B. (2023) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2303.03011 · Cited by 8
“Clinical efficacy of the strains demonstrated that they decrease symptom severity scores related to abdominal pain, distension, bowel habits, and quality of life [15].”
Ren, Z., Zhao, A., Zhang, J., Yang, C., Zhong, W., Mao, S., Wang, S., Yuan, Q., Wang, P., & Zhang, Y. (2022) · Beneficial Microbes · doi:10.3920/bm2021.0132 · Cited by 7
Abdellah, S. A., Scanzi, J., Gal, C., Martin, M., Beck, M., & Ojetti, V. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247446 · Cited by 8
“Similar results have been observed in other studies [26,30,41]; for example, Andresen et al.”
BackgroundResultCao, J., Yu, L., Zhao, J., Zhang, H., Chen, W., Xue, Y., & Zhai, Q. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250153 · Cited by 6
Wang, Q., Yang, Y., Xiao, Y., Liu, Z., Li, M., Yu, Y., Wang, N., Li, J., Li, X., Xu, C., et al. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.05.001 · Cited by 8
Bang, W. Y., Moon, J. S., Kim, H., Lee, H. B., Kim, D.-G., Shin, M., Jung, Y. H., Shin, J., & Yang, J. (2025) · Microorganisms · doi:10.3390/microorganisms13102283 · Cited by 10
Wang, X. C., Xiao, T., Lu, M., Wu, Z., Chen, L., Zhang, Z., & Lu, W. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1410681 · Cited by 7
Santonicola, A., Molinari, R., Piccinocchi, G., Salvetti, A., Natale, F., & Cimmino, G. (2023) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v13i2.1068 · Cited by 8
Zhang, L., Ni, X., Jiang, M.-Z., Du, M., Zhang, S., Jiang, H., Liu, C., & Liu, S. (2024) · Microorganisms · doi:10.3390/microorganisms12061081 · Cited by 9
“Probiotic bacteria effectively relieve the symptoms of CFS and IBS in clinical studies as well as in medical practice [12–14].”
BackgroundEffects of Bifidobacterium longum 35624 in Children and Adolescents with Irritable Bowel Syndrome
Muñoz, S. C., Sandra Verbeke, P., Lydia Lera, M., Pizarro, M. E., Malig, J., & Sorensen, K. (2024) · Nutrients · doi:10.3390/nu16121967 · Cited by 6
“A notable placebo effect has been reported in IBS studies [33], with an average decrease in composite IBS-SSS score of 30 points with placebo having been reported [34].”
BackgroundChanges in antioxidant capacity and gut microbiota in mice after intake of camel milk
Wang, J., Ren, W., Liu, S., Li, Z., Zeng, Y., Meng, J., & Yao, X. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1621031 · Cited by 6
Maslennikov, R. V., Gosteeva, E., Ananeva, V., Korshunova, L., Kravtsowa, A., Poluektova, E., Ulyanin, A. I., Sigidaev, A. S., Kikhasurova, P. M., & Ivashkin, V. T. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15031152 · Cited by 15
Tang, A. S. P., Quek, J., Sulaimi, F., Sim, B., Kai, T. O. S., Soon, E. Y., Goh, C. N., Hsu, J. L. J., Lee, C. K. L., Chong, S. K. S., et al. (2026) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70322 · Cited by 8
Wagner, N. R. F., Lopes, M. C. P., Fernandes, R., Taconeli, C. A., Nascimento, G. M., Pessini, J., Trindade, E. B. S. D. M., & Campos, A. C. L. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07117-4 · Cited by 5
Role of microbiota in pain: From bench to bedside
Ren, H., Cao, B., Xu, Q., Zhao, R., Li, H., & Wei, B. (2025) · iMetaOmics. · doi:10.1002/imo2.58 · Cited by 9
Bertuccioli, A., Sisti, D., Lazzerini, N., Palazzi, C. M., Zonzini, G. B., Ragazzini, M., & Belli, A. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1604319 · Cited by 7
Traynard, V. (2024) · Nutrients · doi:10.3390/nu16223927 · Cited by 5
Rokkas, T., Ekmektzoglou, K. A., Tsanou, E., Bricca, L., Menni, A.-E., Golfakis, P., & Kotzampassi, K. E. (2025) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000003062 · Cited by 7
Oh, C. K., Park, J.-K., Kim, Y. J., & Kim, J. (2023) · Medicine · doi:10.1097/md.0000000000034899 · Cited by 4
“[13,14] Gut microbiota is considered one of the factors that may play an important role in the pathophysiology of IBS.”
BackgroundResultInfluentialManandhar, A., Sabir, G., Abdelhady, H. A., Abakar, A. O., Gangavarapu, R. R., Mahmud, S. A., & Malasevskaia, I. A. (2024) · Cureus · doi:10.7759/cureus.72089 · Cited by 5
“…scores, standard of living [19,23], and specific symptoms like abdominal pain and bloating in the probiotic groups compared to placebo [12,14,21,22], other trials did not find any statistically significant changes between the probiotic and placebo groups [11,15-17 , Nonetheless, some studies…”
Jiang, H., Li, R., Zhang, F., Zhou, F., Lin, J., Kong, N., Chen, H., Guo, L., Ye, C., Li, F., et al. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/4463063 · Cited by 5
Namkieat, P., Borompichaichartkul, C., Ayuni, D., Sapwarobol, S., & Phumsombat, P. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107358 · Cited by 7
Primer consenso centroamericano y del Caribe del síndrome de intestino irritable
Galdámez, J., Aguilar-Paiz, L., Blanco, G. M., Monge, S. C., de Mezerville-Cantillo, L., Castillo, P. N., Quintero, I., Polanco, E. D. P. R., Hernández, M. A. S., Sandoval, E., et al. (2023) · Acta gastroenteorológica latinoamericana/Acta gastroenterológica latinoamericana · doi:10.52787/agl.v53i2.272 · Cited by 4
“Los probióticos que contienen multicepas y especies de Bifidobacterium tuvieron el efecto más sólido en la mejoría de los síntomas globales del SII, y los que contienen lactobacilos redujeron significativamente la distensión abdominal y la flatulencia y mejoraron la calidad de vida de los pacientes.154 Hay estudios y…”
BackgroundUpdated Insights into Probiotic Interventions for Metabolic Syndrome: Mechanisms and Evidence
Chen, L., Tian, L., Zhang, Y., Shi, Y., Yuan, W., Zou, Y. L., Zhang, Q., Chen, M., & Zeng, P. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10554-x · Cited by 4
Manvelyan, A., Grigoryan, B. A., Chikindas, M. L., Todorov, S. D., & Pepoyan, A. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10878-8 · Cited by 3
Попов, В. В., Grechanyi, A. N., & Novikova, I. A. (2023) · Science and Innovations in Medicine · doi:10.35693/2500-1388-2023-8-2-87-95 · Cited by 5
van der Geest, A. M., Schukking, I., Brummer, R. J., Pieterse, H., van den Nieuwboer, M., van de Burgwal, L., & Larsen, O. F. A. (2022) · Beneficial Microbes · doi:10.3920/bm2021.0124 · Cited by 4
Dong, S., Hao, F., Xue, B., Wu, S., Zhong, R., Liao, Z., Han, H., & Fang, X. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250201 · Cited by 2
Xiong, Y., Wang, D., Shi, X., Song, X., Liu, Z., Yang, Y., Gao, Y., Gong, Y., Lu, J., Ding, Y., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.121079 · Cited by 3
Marasco, G., Cremon, C., Barbaro, M. R., Stanghellini, V., & Barbara, G. (2024) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001964 · Cited by 5
“60 On the other hand, 4 large studies assessed the effect of probiotics in patients with IBS diagnosed with Rome III criteria, and speci fi cally 2 used live bacteria; a study on 200 patients using a speci fi c probiotic ( Clostridium butyricum ) showed an improvement in overall symptoms, quality of…”
BackgroundJin, Y.-J., Park, Y.-J., Choi, J., Kim, M.-S., Min, U.-G., Lim, J.-H., Kang, J., Lee, D. Y., & Kim, B. (2025) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2412.12056 · Cited by 4
“For instance, L. acidophilus DDS-1 and B. lactis UABla-12, which are included in Lacto-5X, have been shown to improve abdominal pain, bowel habits, stool consistency, and responder rate in IBS patients [33].”
Лазебник, Л. Б. (2025) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-233-1-77-85 · Cited by 2
Judkins, T. C., Oula, M.-L., Sims, S. M., & Langkamp‐Henken, B. (2022) · Trials · doi:10.1186/s13063-022-06410-w · Cited by 3
Irritable Bowel Syndrome in the Elderly Population: A Comprehensive Review
Oba, E. R. V., Morán, A. C. A., Cortés, E. C., Oba, M. I. V., Loeza, B. M. L., & Rodríguez-Orozco, A. R. (2024) · Cureus · doi:10.7759/cureus.68156 · Cited by 5
“In another trial, improvement of IBS symptom severity particularly abdominal pain was associated with L. acidophilus DDS-1 and B. lactis UABla-12 treatment [59].”
BackgroundWang, Z., Chen, Y., Li, X., Li, L., Chen, B., Chen, M., & Zheng, H. (2025) · Quality of Life Research · doi:10.1007/s11136-025-03927-w · Cited by 2
Effects of Lactobacillus Acidophilus Mediated Improvement of Intestinal Barrier in Mice with Autism
Song, Y., Shi, J., Fu, X., Fu, D. B., Xu, L., Liu, W., Cao, J., Ding, Y., Huang, S. Q., Zhou, L., et al. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10827-5 · Cited by 3
Yang, L., Guo, T., Wei, Y., Zhang, Z., Sun, Y., Yan, N., Ding, S., Jiang, L., & Liu, H. (2026) · Physiology & Behavior · doi:10.1016/j.physbeh.2026.115229 · Cited by 2
Dimri, A., Sharma, P., Vishvakarma, R., & Sharma, S. (2026) · Current Nutrition Reports · doi:10.1007/s13668-026-00781-1 · Cited by 1
“…abundance of Lactobacillus in diseased and non-diseased hosts [ 37, 38 ]; and administer - ing specific Lactobacillus strains ameliorates the symptoms, preventing the relapse of several gut diseases like IBD, irritable bowel syndrome [ 39], diarrhea, and Helicobacter pylori infection [ 40, 41 ].”
Biotic therapies for irritable bowel syndrome: current interventions
Wodarczyk, G., Winte, M. F., Mastellone, D., Singh, T., DeSipio, J., & Phadtare, S. (2026) · Gastroenterology report · doi:10.1093/gastro/goag062 · Cited by 1
“…and interference with life ( P =0.012) · Improved quality of life according to SF-12 ( P =0.038) Lactobacillus and Bifidobacterium · 330 adults [39] · IBS according to Rome IV criteria · Arm 1 ( Lactobacillus acidophilus DDS-1) · Arm 2 ( Bifidobacterium ani-malis subsp. lactis UAB1a-12) · 10…”
InfluentialLu, M., Fan, X., Zheng, Y., Kong, W., Ji, R., & Xie, H. (2022) · ScienceAsia · doi:10.2306/scienceasia1513-1874.2022.021 · Cited by 1
“On clinical trials, Lactobacillus probiotics [13, 14] and multispecies probiotics [15], which contains the SCFAs-producing bacteria, have shown therapeutic effects on IBS-D patients.”
BackgroundProbiotics for gastrointestinal health and disease treatment
Lacerda, D. C., da Costa, P. C. T., do Nascimento, L. C. P., & Alves, J. L. D. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89908-6.00022-4 · Cited by 1
Probiotics for oral health and disease treatment
Meurman, J. H., & Stamatova, I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89908-6.00008-x · Cited by 1
Efficacy of probiotics for the treatment of irritable bowel syndrome
Tsukanov, V. V., Vasyutin, A. V., & Tonkikh, Y. L. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-15-119-126 · Cited by 4
Metadata
- Authors
- Martoni, C. J., Srivastava, S., & Leyer, G. J.
- Affiliations
- UAS Laboratories LLC, 4375 Duraform Lane, Windsor, WI 53598, USA
- Vedic Lifesciences (India) (IN)
- Corresponding author
- Leyer, Gregory J.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-01-30
- Volume
- 12
- Issue
- 2
- Pages
- 363
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7071206
- OpenAlex
- W3004290421
- Cited by
- 123
- References
- 50
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 25 · 2023: 22 · 2022: 25 · 2021: 8 · 2020: 6
- FWCI
- 13.25
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- irritable bowel syndrome, probiotics, abdominal pain, symptom severity, abdominal distension, bowel habits, stool consistency, quality of life, Rome IV criteria
- MeSH terms
- Bifidobacterium animalis, Adolescent, Adult, Aged, Double-Blind Method, Female, Humans, Lactobacillus acidophilus, Male, Middle Aged, Severity of Illness Index, Abdominal Pain, Treatment Outcome, Probiotics, Irritable Bowel Syndrome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.